Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.
Mitsubishi UFJ Financial Group, Inc. has ceased to be a substantial holder in Australian Clinical Labs Limited as of March 10, 2025. This change in substantial holding, primarily due to the purchase of securities by an entity controlled by Morgan Stanley, may impact the company’s shareholder structure and influence its market dynamics.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Limited operates in the healthcare industry, providing pathology services across Australia. The company focuses on delivering comprehensive laboratory testing and diagnostic services to support medical practitioners and patients.
YTD Price Performance: -10.17%
Average Trading Volume: 672,033
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$616.1M
See more data about ACL stock on TipRanks’ Stock Analysis page.